Advanced search
Publication Cover
Cancer Investigation Volume 24, 2006 - Issue 4
Submit an article Journal homepage
77
Views
12
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

A Phase II Trial of Vinorelbine in Patients with Advanced Gastroesophageal Adenocarcinoma

Matthew H. Kulke Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA
, M.D.,
Alona Muzikansky Department of Biostatistics, Massachusetts General Hospital, Boston, Massachusetts, USA
, M.A.,
Jeffrey Clark Division of Hematology/Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA
, M.D.,
Peter C. Enzinger Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA
, M.D.,
Panos Fidias Division of Hematology/Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA
, M.D.,
Kate Kinsella Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA
, B.S.,
Ann Michelini Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA
, RN, MSN &
Charles S. Fuchs Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA; Channing Laboratory, Brigham and Women's Hospital, Boston, Massachusetts, USA
, M.D., MPH show all
Pages 346-350 | Published online: 11 Jun 2009

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Madhusmita Dhupal & Devasish Chowdhury. (2020) Phytochemical-Based Nanomedicine for Advanced Cancer Theranostics: Perspectives on Clinical Trials to Clinical Use. International Journal of Nanomedicine 15, pages 9125-9157.
Read now

Articles from other publishers (11)

Yang Zheng, Jiayu Zou, Chen Sun, Fu Peng & Cheng Peng. (2023) Ado-tratuzumab emtansine beyond breast cancer: therapeutic role of targeting other HER2-positive cancers. Frontiers in Molecular Biosciences 10.
Crossref
Masahiko Aoki, Satoru Iwasa & Narikazu Boku. (2021) Trastuzumab deruxtecan for the treatment of HER2-positive advanced gastric cancer: a clinical perspective. Gastric Cancer 24:3, pages 567-576.
Crossref
Peter C Thuss-Patience, Manish A Shah, Atsushi Ohtsu, Eric Van Cutsem, Jaffer A Ajani, Hugo Castro, Wasat Mansoor, Hyun Cheol Chung, Gyorgy Bodoky, Kohei Shitara, Gail D Lewis Phillips, Tina van der Horst, Marie-Laurence Harle-Yge, Betsy L Althaus & Yoon-Koo Kang. (2017) Trastuzumab emtansine versus taxane use for previously treated HER2-positive locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GATSBY): an international randomised, open-label, adaptive, phase 2/3 study. The Lancet Oncology 18:5, pages 640-653.
Crossref
Yue-shen Wang, Jing Tian, Yong Han, Shu-mei Han & Sheng-bin Shi. (2016) Gemcitabine Plus Vinorelbine as Second-Line Therapy in Patients With Metastatic Esophageal Cancer Previously Treated With Platinum-Based Chemotherapy. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 24:2, pages 129-135.
Crossref
A. William BlackstockJr.Jr. & Suzanne Russo. 2016. Clinical Radiation Oncology. Clinical Radiation Oncology 843 864.e7 .
Raelene M. Wouda, Mairin E. Miller, Esther Chon & Timothy J. Stein. (2015) Clinical effects of vinorelbine administration in the management of various malignant tumor types in dogs: 58 cases (1997–2012). Journal of the American Veterinary Medical Association 246:11, pages 1230-1237.
Crossref
Matthew D. Galsky, Daniel D. Von Hoff, Marcus Neubauer, Thomas Anderson, Mark Fleming, Yasir Nagarwala, Janine M. Mahoney, Dawn Midwinter, Linda Vocila & Tal Z. Zaks. (2010) Target-specific, histology-independent, randomized discontinuation study of lapatinib in patients with HER2-amplified solid tumors. Investigational New Drugs 30:2, pages 695-701.
Crossref
A. William BlackstockJr.Jr. & Suzanne Russo. 2012. Clinical Radiation Oncology. Clinical Radiation Oncology 839 858 .
Matthew D. Galsky, Tal Zaks, Habib Hassani, Linda Vocila, Guru Sonpavde, Thomas E. Hutson & Daniel D. Von Hoff. (2009) Target-specific randomized discontinuation trial design: a novel approach in molecular therapeutics. Investigational New Drugs 28:2, pages 194-198.
Crossref
Florian Lordick & Dirk Jäger. 2009. Platinum and Other Heavy Metal Compounds in Cancer Chemotherapy. Platinum and Other Heavy Metal Compounds in Cancer Chemotherapy 251 270 .
M. Albertsson, B. Johansson, S. Friesland, L. Kadar, H. Letocha, G. Frykholm & G. Wagenius. (2007) Phase II studies on docetaxel alone every third week, or weekly in combination with gemcitabine in patients with primary locally advanced, metastatic, or recurrent esophageal cancer. Medical Oncology 24:4, pages 407-412.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.